Literature DB >> 31977292

SWI/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models.

Yemin Wang1,2,3, Lien Hoang2, Jennifer X Ji1,2, David G Huntsman1,2,3.   

Abstract

The SWI/SNF (mating type SWItch/Sucrose NonFermentable) chromatin remodeling complexes interact with histones and transcription factors to modulate chromatin structure and control gene expression. These evolutionarily conserved multisubunit protein complexes are involved in regulating many biological functions, such as differentiation and cell proliferation. Genomic studies have revealed frequent mutations of genes encoding multiple subunits of the SWI/SNF complexes in a wide spectrum of cancer types, including gynecologic cancers. These SWI/SNF mutations occur at different stages of tumor development and are restricted to unique histologic types of gynecologic cancers. Thus, SWI/SNF mutations have to function in the appropriate tissue and cell context to promote gynecologic cancer initiation and progression. In this review, we summarize the current knowledge of SWI/SNF mutations in the development of gynecologic cancers to provide insights into both molecular pathogenesis and possible treatment implications for these diseases.

Entities:  

Keywords:  ARID1A; DDEC; SCCOHT; SMARCA4; SWI/SNF; clear cell carcinoma of the ovary; dedifferentiated endometrial carcinoma; small cell carcinoma of the ovary hypercalcemic type

Mesh:

Substances:

Year:  2020        PMID: 31977292      PMCID: PMC6986318          DOI: 10.1146/annurev-pathmechdis-012418-012917

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  143 in total

1.  Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

Authors:  Elvio G Silva; Michael T Deavers; Diane C Bodurka; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2006-01       Impact factor: 2.762

2.  Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency.

Authors:  Abbas Agaimy; Liang Cheng; Lars Egevad; Bernd Feyerabend; Ondřej Hes; Bastian Keck; Stefano Pizzolitto; Stefano Sioletic; Bernd Wullich; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2017-02       Impact factor: 6.394

3.  ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.

Authors:  Bin Guan; Tian-Li Wang; Ie-Ming Shih
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

4.  Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5.

Authors:  Charles W M Roberts; Monique M Leroux; Mark D Fleming; Stuart H Orkin
Journal:  Cancer Cell       Date:  2002-11       Impact factor: 31.743

5.  ARID1A mutations in endometriosis-associated ovarian carcinomas.

Authors:  Kimberly C Wiegand; Sohrab P Shah; Osama M Al-Agha; Yongjun Zhao; Kane Tse; Thomas Zeng; Janine Senz; Melissa K McConechy; Michael S Anglesio; Steve E Kalloger; Winnie Yang; Alireza Heravi-Moussavi; Ryan Giuliany; Christine Chow; John Fee; Abdalnasser Zayed; Leah Prentice; Nataliya Melnyk; Gulisa Turashvili; Allen D Delaney; Jason Madore; Stephen Yip; Andrew W McPherson; Gavin Ha; Lynda Bell; Sian Fereday; Angela Tam; Laura Galletta; Patricia N Tonin; Diane Provencher; Dianne Miller; Steven J M Jones; Richard A Moore; Gregg B Morin; Arusha Oloumi; Niki Boyd; Samuel A Aparicio; Ie-Ming Shih; Anne-Marie Mes-Masson; David D Bowtell; Martin Hirst; Blake Gilks; Marco A Marra; David G Huntsman
Journal:  N Engl J Med       Date:  2010-09-08       Impact factor: 91.245

6.  The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.

Authors:  Gautier Chene; Veronique Ouellet; Kurosh Rahimi; Veronique Barres; Diane Provencher; Anne Marie Mes-Masson
Journal:  Int J Gynaecol Obstet       Date:  2015-04-11       Impact factor: 3.561

7.  Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases.

Authors:  G R Dickersin; I W Kline; R E Scully
Journal:  Cancer       Date:  1982-01-01       Impact factor: 6.860

8.  Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

Authors:  Dinorah Friedmann-Morvinski; Eric A Bushong; Eugene Ke; Yasushi Soda; Tomotoshi Marumoto; Oded Singer; Mark H Ellisman; Inder M Verma
Journal:  Science       Date:  2012-10-18       Impact factor: 47.728

9.  Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Authors:  Joseph J Caumanns; Katrien Berns; G Bea A Wisman; Rudolf S N Fehrmann; Tushar Tomar; Harry Klip; Gert J Meersma; E Marielle Hijmans; Annemiek M C Gennissen; Evelien W Duiker; Desiree Weening; Hiroaki Itamochi; Roelof J C Kluin; Anna K L Reyners; Michael J Birrer; Helga B Salvesen; Ignace Vergote; Els van Nieuwenhuysen; James Brenton; E Ioana Braicu; Jolanta Kupryjanczyk; Beata Spiewankiewicz; Lorenza Mittempergher; René Bernards; Ate G J van der Zee; Steven de Jong
Journal:  Clin Cancer Res       Date:  2018-04-23       Impact factor: 12.531

10.  The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level.

Authors:  Aaron R Goldman; Benjamin G Bitler; Zachary Schug; Jose R Conejo-Garcia; Rugang Zhang; David W Speicher
Journal:  Mol Cell Proteomics       Date:  2016-09-21       Impact factor: 5.911

View more
  12 in total

1.  Discovering biomarkers for hormone-dependent tumors: in silico study on signaling pathways implicated in cell cycle and cytoskeleton regulation.

Authors:  Klaudia Waszczykowska; Karolina Prażanowska; Żaneta Kałuzińska; Damian Kołat; Elżbieta Płuciennik
Journal:  Mol Genet Genomics       Date:  2022-05-09       Impact factor: 3.291

Review 2.  High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile.

Authors:  Tavonna D Kako; Maahum Z Kamal; Jhalak Dholakia; Carly B Scalise; Rebecca C Arend
Journal:  Int J Clin Oncol       Date:  2022-01-17       Impact factor: 3.402

3.  ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription.

Authors:  Chunhong Yu; Xiaoyun Lei; Fang Chen; Song Mao; Lu Lv; Honglu Liu; Xueying Hu; Runhan Wang; Licong Shen; Na Zhang; Yang Meng; Yunfan Shen; Jiale Chen; Pishun Li; Shi Huang; Changwei Lin; Zhuohua Zhang; Kai Yuan
Journal:  Nat Commun       Date:  2022-06-17       Impact factor: 17.694

Review 4.  Histopathologic diagnosis of endometrial precancers: Updates and future directions.

Authors:  Hao Chen; Amanda L Strickland; Diego H Castrillon
Journal:  Semin Diagn Pathol       Date:  2021-12-10       Impact factor: 3.893

Review 5.  ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.

Authors:  Olena Odnokoz; Cindy Wavelet-Vermuse; Shelby L Hophan; Serdar Bulun; Yong Wan
Journal:  Epigenomics       Date:  2021-04-23       Impact factor: 4.778

6.  Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.

Authors:  Mitzi Aguilar; He Zhang; Musi Zhang; Brandi Cantarell; Subhransu S Sahoo; Hao-Dong Li; Ileana C Cuevas; Jayanthi Lea; David S Miller; Hao Chen; Wenxin Zheng; Jeffrey Gagan; Elena Lucas; Diego H Castrillon
Journal:  J Pathol       Date:  2021-03-09       Impact factor: 7.996

Review 7.  Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review.

Authors:  Eleftherios P Samartzis; S Intidhar Labidi-Galy; Michele Moschetta; Mario Uccello; Dimitrios R Kalaitzopoulos; J Alejandro Perez-Fidalgo; Stergios Boussios
Journal:  Ann Transl Med       Date:  2020-12

8.  Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.

Authors:  Yu-Chien Lin; Kuo-Chang Wen; Pi-Lin Sung; Yu-Ting Chou; Phui-Ly Liew; Lin-Yu Chen; Rui-Lan Huang; Hung-Cheng Lai; Lu-Te Chang
Journal:  J Ovarian Res       Date:  2020-12-08       Impact factor: 4.234

9.  Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.

Authors:  Makiko Omi; Akiko Tonooka; Tomohiro Chiba; Yuji Tanaka; Atsushi Fusegi; Yoichi Aoki; Hidetaka Nomura; Hiroyuki Kanao; Yutaka Takazawa
Journal:  Diagn Pathol       Date:  2020-09-24       Impact factor: 2.644

10.  Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.

Authors:  Yemin Wang; Valerie Lan Tao; Chae Young Shin; Clara Salamanca; Shary Yuting Chen; Christine Chow; Martin Köbel; Susana Ben-Neriah; David Farnell; Christian Steidl; Jessica N Mcalpine; C Blake Gilks; David G Huntsman
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.